Yes, benzodiazepines increase dopamine activity in the brain’s reward system. The effect is indirect and works through a mechanism called disinhibition, where benzos silence the cells that normally keep dopamine neurons in check. This dopamine increase is central to why benzodiazepines carry a risk of dependence and addiction, even though they’re primarily known as sedatives.
How Benzos Increase Dopamine
Benzodiazepines don’t stimulate dopamine neurons directly. Instead, they work through a two-step process in a brain region called the ventral tegmental area (VTA), which is the origin point for the brain’s reward circuitry. In this region, small inhibitory neurons act like a brake on dopamine-producing neurons, keeping them from firing too much. Benzos strengthen that brake on the brake, effectively releasing dopamine neurons to fire more freely.
Here’s what happens at the cellular level. The inhibitory neurons in the VTA have a specific type of receptor (containing a component called the alpha-1 subunit) that benzodiazepines bind to very effectively. When a benzo locks onto these receptors, it amplifies the calming signal so strongly that the inhibitory neurons slow down dramatically or stop firing altogether. With those neurons silenced, there’s nothing holding back the dopamine neurons, so they ramp up their activity. Research published in Nature confirmed that benzodiazepines suppress the firing of these inhibitory neurons to the point of “complete spike suppression” in some cases.
This mechanism is remarkably similar to how opioids boost dopamine. Opioids also work by removing the inhibitory brake on dopamine neurons in the VTA, just through a different receptor. Both drug classes end up at the same result: more dopamine flowing into the nucleus accumbens, the brain region most associated with reward and reinforcement.
What the Dopamine Increase Looks Like
The way benzos alter dopamine release is unusual. Research using real-time dopamine monitoring in animals found that diazepam (Valium) increases the frequency of dopamine release events in the nucleus accumbens while simultaneously decreasing the size of each individual burst. So the brain gets more frequent pulses of dopamine, but each pulse is smaller.
This pattern differs from stimulants like cocaine or amphetamines, which produce large, sustained surges of dopamine. The benzo effect is subtler, which likely explains why the subjective “high” from benzos is less intense than from stimulants but still reinforcing enough to drive repeated use. When benzos are combined with opioids, however, the dopamine effect becomes synergistic, meaning the combined increase is greater than what either drug would produce alone. This is one reason the combination is particularly dangerous and habit-forming.
Why This Matters for Addiction
The dopamine increase from benzodiazepines isn’t just a pharmacological curiosity. It’s the core mechanism behind their addictive potential. Like all drugs that can cause addiction, benzos trigger changes in the connections between neurons in the reward system. These changes start at the VTA and, with repeated exposure, spread to other brain regions, gradually rewiring the circuitry that governs motivation and reward-seeking behavior.
Animal studies have pinpointed the alpha-1 receptor subunit as the critical player. When researchers genetically modified mice so that their alpha-1 receptors no longer responded to benzodiazepines, something striking happened: the drug could no longer silence the inhibitory neurons, could no longer increase dopamine neuron firing, and could no longer trigger the synaptic rewiring associated with addiction. Most tellingly, these mice showed no preference for a solution containing a benzodiazepine over plain water, while normal mice strongly preferred the drug-containing solution. This confirms that the dopamine-boosting mechanism is what makes benzos reinforcing.
Tolerance develops within weeks of regular use, meaning the brain adapts and the same dose produces a weaker effect over time. This can push people toward higher doses to achieve the same feeling, deepening the cycle of dependence.
What Happens to Dopamine During Withdrawal
When someone abruptly stops taking benzodiazepines after regular use, the dopamine system doesn’t simply return to normal. The brain enters a state of reduced inhibitory signaling, and dopamine levels in key regions can drop below their baseline. This creates a neurochemical environment that’s essentially the opposite of what the drug was providing: less dopamine activity in the circuits responsible for motivation, pleasure, and movement.
This drop in dopamine during withdrawal helps explain some of the psychological symptoms people experience, including low mood, lack of motivation, and difficulty feeling pleasure. In severe cases, the combination of disrupted inhibitory signaling and suppressed dopamine can contribute to a state resembling catatonia, characterized by rigidity and unresponsiveness. Clinical reports have documented cases where abrupt benzo withdrawal created enough dopamine suppression to make patients unusually vulnerable to complications from other medications that further lower dopamine.
This is why gradual tapering, rather than sudden discontinuation, is standard practice for anyone who has been taking benzodiazepines regularly. A slow taper gives the brain time to readjust its inhibitory and dopamine systems incrementally rather than all at once.
Benzos Compared to Other Drug Classes
Addictive drugs generally fall into categories based on how they increase dopamine. Stimulants like cocaine block the recycling of dopamine, causing it to accumulate. Opioids, cannabinoids, and benzodiazepines all work through disinhibition, removing the inhibitory brake on dopamine neurons, but each uses a different receptor to do it. Opioids act through mu-opioid receptors on the inhibitory neurons, while benzos act through alpha-1 containing receptors on those same cells.
The practical difference is magnitude. Stimulants produce the largest and most rapid dopamine surges. Opioids produce moderate to large increases. Benzodiazepines produce a more modest effect, with more frequent but smaller dopamine pulses. This graded difference in dopamine impact roughly tracks with how quickly each drug class tends to produce compulsive use, though individual vulnerability varies significantly. The fact that benzos occupy the lower end of the dopamine spectrum doesn’t make them safe from an addiction standpoint. It simply means the path to dependence is often slower and less obvious, which can make it harder to recognize until it’s well established.